#EULAR2022
Joint and skin involvement in SLE
🔹50% respond to HCQ
🔹HCQ non responders can respond to CQ
🔹HCQ blood levels help in monitoring
Joint and skin involvement in SLE
🔹50% respond to HCQ
🔹HCQ non responders can respond to CQ
🔹HCQ blood levels help in monitoring
#EULAR2022
Joint and skin involvement in SLE
🔹Thalidomide Effective but high relapse rates and ADRs
🔹 Response starts 👉🏻 2 weeks, peaks 👉🏻 4-8 weeks
🔹SCLE,DLE>>> lupus Profundus
Joint and skin involvement in SLE
🔹Thalidomide Effective but high relapse rates and ADRs
🔹 Response starts 👉🏻 2 weeks, peaks 👉🏻 4-8 weeks
🔹SCLE,DLE>>> lupus Profundus
#EULAR2022
Joint and skin involvement in SLE
🔹 Dapsone DOC in bullous Lupus
🔹 RTX in resistant cases
Joint and skin involvement in SLE
🔹 Dapsone DOC in bullous Lupus
🔹 RTX in resistant cases
#EULAR2022
Joint and skin involvement in SLE
🔹Iberdomide is the new kid on the block
🔹Cfficacy: SCLE>DLE>>ACLE
Ritux 🤔 the judgement is still out
Joint and skin involvement in SLE
🔹Iberdomide is the new kid on the block
🔹Cfficacy: SCLE>DLE>>ACLE
Ritux 🤔 the judgement is still out
#EULAR2022
Joint and skin involvement in SLE
🔹 Anifrolumab effective
🔹Litifilimab promising
🔹BDCA inhibitors look good too
Joint and skin involvement in SLE
🔹 Anifrolumab effective
🔹Litifilimab promising
🔹BDCA inhibitors look good too
Loading suggestions...